137 related articles for article (PubMed ID: 12013113)
1. Interferons and their receptors in human papillomavirus lesions of the uterine cervix.
Cintorino M; Tripodi SA; Romagnoli R; Ietta F; Ricci MG; Paulesu L
Eur J Gynaecol Oncol; 2002; 23(2):145-50. PubMed ID: 12013113
[TBL] [Abstract][Full Text] [Related]
2. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.
Clerici M; Merola M; Ferrario E; Trabattoni D; Villa ML; Stefanon B; Venzon DJ; Shearer GM; De Palo G; Clerici E
J Natl Cancer Inst; 1997 Feb; 89(3):245-50. PubMed ID: 9017005
[TBL] [Abstract][Full Text] [Related]
3. [Gamma interferon (IFN-gamma), tumor necrosis factor alpha (TNF-alpha) and interleukins 2, 4 and 6 (IL-2, IL-4, IL-6) in cervical-uterine cells of intraepithelial neoplasia: a preliminary report].
Pardo-Govea T; Callejas D; Núñez-Troconis J; Araujo M; Costa L; Pons H; Delgado M; Monsalve F
Invest Clin; 2005 Mar; 46(1):5-13. PubMed ID: 15782532
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of invariant NKT cells with increased IFN-γ production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia.
Hu T; Yang P; Zhu H; Chen X; Xie X; Yang M; Liu S; Wang H
Diagn Pathol; 2015 Apr; 10():20. PubMed ID: 25885042
[TBL] [Abstract][Full Text] [Related]
5. Local expression of interferon-alpha and interferon receptors in cervical intraepithelial neoplasia.
Tirone NR; Peghini BC; Barcelos AC; Murta EF; Michelin MA
Cancer Immunol Immunother; 2009 Dec; 58(12):2003-10. PubMed ID: 19381629
[TBL] [Abstract][Full Text] [Related]
6. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load(1).
Heard I; Tassie JM; Schmitz V; Mandelbrot L; Kazatchkine MD; Orth G
Obstet Gynecol; 2000 Sep; 96(3):403-9. PubMed ID: 10960634
[TBL] [Abstract][Full Text] [Related]
7. Presence of multiple human papillomavirus types in cervical samples from HIV-infected women.
Levi JE; Fernandes S; Tateno AF; Motta E; Lima LP; Eluf-Neto J; Pannuti CS
Gynecol Oncol; 2004 Jan; 92(1):225-31. PubMed ID: 14751163
[TBL] [Abstract][Full Text] [Related]
8. Production of interferons and change of the lymphocyte subpopulation phenotype in peripheral blood at cervical papillomavirus infection.
Lazarenko L; Spivak M; Lakatosh V; Kryvokhatska L; Mikhailenko O; Rudenko A; Tkáciková L; Mikula I
Folia Microbiol (Praha); 2002; 47(6):747-52. PubMed ID: 12630331
[TBL] [Abstract][Full Text] [Related]
9. IFN-κ, a novel type I IFN, is undetectable in HPV-positive human cervical keratinocytes.
DeCarlo CA; Severini A; Edler L; Escott NG; Lambert PF; Ulanova M; Zehbe I
Lab Invest; 2010 Oct; 90(10):1482-91. PubMed ID: 20479716
[TBL] [Abstract][Full Text] [Related]
10. [Interferon-alpha controls HPV infection in cervix epithelium].
Labeit D; Labeit S; Berger M; Gallati H; Rosenberg R; Friese K
Zentralbl Gynakol; 1995; 117(11):566-77. PubMed ID: 8533490
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of IL-10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer.
El-Sherif AM; Seth R; Tighe PJ; Jenkins D
J Pathol; 2001 Sep; 195(2):179-85. PubMed ID: 11592096
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of IFN-gamma by CD8(+) T cells is preserved in HIV-infected women with HPV-related cervical squamous intraepithelial lesions.
Lee BN; Follen M; Tortolero-Luna G; Eriksen N; Helfgott A; Hammill H; Shearer WT; Reuben JM
Gynecol Oncol; 1999 Dec; 75(3):379-86. PubMed ID: 10600293
[TBL] [Abstract][Full Text] [Related]
13. Serological responses to human papillomavirus type 6 and 16 virus-like particles in patients with cervical neoplastic lesions.
Sasagawa T; Inoue M; Lehtinen M; Zhang W; Gschmeissner SE; Hajibagheri MA; Finch J; Crawford L
Clin Diagn Lab Immunol; 1996 Jul; 3(4):403-10. PubMed ID: 8807204
[TBL] [Abstract][Full Text] [Related]
14. Abnormal expression of galactosyl(alpha 1-->3) galactose epitopes in squamous cells of the uterine cervix infected by human papillomavirus.
Tremont-Lukats IW; Avila JL; Tapia F; Hernández D; Cáceres-Dittmar G; Rojas M
Pathobiology; 1996; 64(5):239-46. PubMed ID: 9068006
[TBL] [Abstract][Full Text] [Related]
15. Antibody levels against galactosyl (alpha1 --> 3) galactose epitopes in cervical mucus from patients with human papillomavirus infection.
Hernàndez DE; Cohen A; Fisher D; Correnti M; Harner R
Gynecol Oncol; 2002 Mar; 84(3):374-7. PubMed ID: 11855872
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix.
Monnier-Benoit S; Mauny F; Riethmuller D; Guerrini JS; Căpîlna M; Félix S; Seillès E; Mougin C; Prétet JL
Gynecol Oncol; 2006 Jul; 102(1):22-31. PubMed ID: 16427684
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cervical and blood T-cell responses to human papillomavirus-16 in women with human papillomavirus-associated cervical intraepithelial neoplasia.
Passmore JA; Milner M; Denny L; Sampson C; Marais DJ; Allan B; Gumbi PP; Hitzeroth II; Rybicki EP; Williamson AL
Immunology; 2006 Dec; 119(4):507-14. PubMed ID: 17026720
[TBL] [Abstract][Full Text] [Related]
18. The importance of alpha/beta (alpha/13) interferon receptors and signaling pathways for the treatment of cervical intraepithelial neoplasias.
Montes L; Andrade CM; Michelin MA; Murta EF
Eur J Gynaecol Oncol; 2014; 35(4):368-72. PubMed ID: 25118475
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus (HPV) and Epstein-Barr virus (EBV) cervical infections in women with normal and abnormal cytology.
Szkaradkiewicz A; Wal M; Kuch A; Pieta P
Pol J Microbiol; 2004; 53(2):95-9. PubMed ID: 15478354
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia.
de Gruijl TD; Bontkes HJ; Walboomers JM; Schiller JT; Stukart MJ; Groot BS; Chabaud MM; Remmink AJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ
J Natl Cancer Inst; 1997 May; 89(9):630-8. PubMed ID: 9150187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
